2. Signaling Pathways
  3. Immunology/Inflammation
  4. CD276/B7-H3

CD276/B7-H3

B7 homolog 3 protein

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P9966
    Enoblituzumab
    		Inhibitor 99.16%
    Enoblituzumab (MGA271) is a humanized IgG1κ monoclonal antibody recognizing human B7-H3 protein, a member of the B7 family of immune regulators.
    Enoblituzumab
  • HY-P99740
    Mirzotamab
    		Inhibitor 99.45%
    Mirzotamab is an IgG1κ monoclonal antibody targeting to CD276/B7-H3 with anti-tumor activity. Mirzotamab conjugates with Clezutoclax (HY-137774), a BCL inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC).
    Mirzotamab
  • HY-P99157
    Omburtamab
    		Inhibitor 98.27%
    Omburtamab is an anti-CD276 (also known as B7-H3) monoclonal antibody, CD276 is a B7/CD28 immunoglobulin superfamily member expressed among solid human tumours. Omburtamab can bind tumor tissues and be used in various cancers research.
    Omburtamab
  • HY-P990918
    Emiltatug
    HY-P990918 is an VTCN1-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Emiltatug
  • HY-P990996
    Felmetatug
    HY-P990996 is an VTCN1-targeting IgG1κ type human antibody, the recommed isotype control is Human IgG1 kappa, Isotype Control (HY-P99001).
    Felmetatug
  • HY-P990340
    Anti-B7-H3/CD276 Antibody
    		Inhibitor
    Anti-B7-H3/CD276 Antibody is a CHO-expressed human antibody targeting B7-H3/CD276. Anti-B7-H3/CD276 Antibody has a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Anti-B7-H3/CD276 Antibody can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
    Anti-B7-H3/CD276 Antibody
Cat. No. Product Name / Synonyms Application Reactivity